Benzinga | Jan 5, 2021 12:59PM EST

Jon Najarian Sees Unusual Option Activity In Target And Teva

On CNBC's "Fast Money Halftime Report," Jon Najarian gave some unusual option activity plays.

Najarian sees unusual activity in Target (NYSE:TGT) February $185 calls and Teva Pharmaceuticals (NYSE:TEVA) February $12 calls.

Najarian has a position in both of these and will hold for two to three weeks.